Thiogenesis Therapeutics, Corp.
TTIPF
$0.6468
$0.086815.50%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -48.59% | -50.09% | 14.34% | 3.58% | 3.78% |
Total Receivables | -43.63% | -5.42% | 62.39% | -2.25% | 404.29% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -15.78% | -46.27% | 258.82% | 400.00% | 645.59% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -48.11% | -49.52% | 15.55% | 4.28% | 6.29% |
|
|||||
Total Current Assets | -48.11% | -49.52% | 15.55% | 4.28% | 6.29% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -48.11% | -49.52% | 15.55% | 4.28% | 6.29% |
|
|||||
Total Accounts Payable | 166.92% | -69.35% | -66.91% | -14.69% | 33.46% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 171.63% | -70.11% | -66.91% | -14.69% | 33.46% |
|
|||||
Total Current Liabilities | 171.63% | -70.11% | -66.91% | -14.69% | 33.46% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 171.63% | -70.11% | -66.91% | -14.69% | 33.46% |
|
|||||
Common Stock & APIC | -2.44% | -1.33% | 24.83% | 21.39% | 26.59% |
Retained Earnings | -24.79% | -17.71% | -43.68% | -49.04% | -63.43% |
Treasury Stock & Other | -0.56% | -12.94% | 4,808.56% | 10,086.32% | 6,329.67% |
Total Common Equity | -62.28% | -43.15% | 23.40% | 5.80% | 4.92% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -62.28% | -43.15% | 23.40% | 5.80% | 4.92% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -62.28% | -43.15% | 23.40% | 5.80% | 4.92% |
|